Pediatric Venous Thromboembolism: An Update on Predictive Risk Factors, Prevention, and Treatment

Monday, January 22, 2024

9:45 AM – 10:45 AM MT

Location: West-301D

CE: 1.0

Concurrent Session Moderator(s)

Michele Loi, MD, (she/her/hers)

University of Colorado Health Science Center
Aurora
Alison Nair, MD, (she/her/hers)

Associate Clinical Professor
University of California San Francisco Medical Center
San Francisco, California

The incidence and rate of pediatric venous thromboembolism (VTE) has been increasing rapidly, particularly in critically ill children. Because of the historic paucity of evidence-based literature and reliance on extrapolated adult studies, pediatric critical care practices regarding risk analysis, prevention and treatment of VTE vary. Updated information on predictive risk assessment, ongoing studies on effectiveness of hospital-acquired VTE prevention efforts, and new treatment modalities will inform evidence-based prevention and standard of care.

Learning Objectives:

Appraise biomarkers and other predictive risk factors for venous thromboembolic (VTE) events
Interpret the evidence and strategies for the prevention of hospital-acquired VTE events
Summarize past and present treatment modalities for pediatric VTE events

Presentations:

Which Pediatric Patients Are at Risk for Development of Venous Thromboembolism?
Can We Prevent Venous Thromboembolism in Sick Patients?
How Do We Treat Pediatric Venous Thromboembolism?